Literature DB >> 10430264

Determining the site of the primary cancer in patients with skeletal metastasis of unknown origin: a retrospective study.

H Katagiri1, M Takahashi, J Inagaki, H Sugiura, S Ito, H Iwata.   

Abstract

BACKGROUND: When skeletal metastasis is the presenting problem and the primary site is occult, there is a need to identify the primary site as soon as possible. However, the search for the primary tumor is often time-consuming and difficult. The purpose of this study was to analyze the efficacy of particular diagnostic approaches and to devise an efficient and optimal diagnostic strategy.
METHODS: Among 213 patients with skeletal metastasis treated between 1990 and 1996 were 64 in whom skeletal lesions were the first manifestation of malignancy. The authors retrospectively analyzed both the final diagnosis and the process by which it was made in these 64 cases.
RESULTS: The primary cancer was identified antemortem in 56 (88%) of the 64 patients by examination and in 3 patients at autopsy. Lung carcinoma, the most frequently observed primary lesion, was identified in 23 patients. Other primary lesions were prostate carcinoma in 11 patients, breast carcinoma in 5, and hepatocellular carcinoma in 5. The primary malignancy was not determined in 5 patients. Thoracic and abdominal computed tomography (CT) scans were useful, especially in the diagnosis of patients with lung, hepatocellular, renal cell, and pancreatic carcinomas. Tumor markers were abnormally elevated in 73% of patients with carcinomas.
CONCLUSIONS: Although thoracic and abdominal CT scans were useful, examination of the gastrointestinal tract and pelvic CT scan seldom revealed the primary lesion and therefore should not be performed as an initial routine study in the absence of abdominal symptoms. Tumor markers are useful in differentiating carcinoma from hematologic malignancy and primary bone tumor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10430264     DOI: 10.1002/(sici)1097-0142(19990801)86:3<533::aid-cncr24>3.0.co;2-1

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  21 in total

1.  Cytogenetic profile of unknown primary tumors: clues for their pathogenesis and clinical management.

Authors:  Dimitra Pantou; Haroula Tsarouha; Anna Papadopoulou; Louiza Mahaira; Ioannis Kyriazoglou; Nikiforos Apostolikas; Sophia Markidou; Theoni Trangas; Nikos Pandis; Georgia Bardi
Journal:  Neoplasia       Date:  2003 Jan-Feb       Impact factor: 5.715

2.  Sacral metastasis as a presentation of colonic adenocarcinoma.

Authors:  William T H Gelson; Martin J Rimmer; William Landells; Andrew C Douds
Journal:  J R Soc Med       Date:  2007-04       Impact factor: 5.344

3.  FNAB of metastatic lesions with special reference to clinicopathological analysis of primary site in cases of epithelial and non-epithelial tumors.

Authors:  Shamshad Ahmad; Kafil Akhtar; Swati Singh; Shahid Siddiqui
Journal:  J Cytol       Date:  2011-04       Impact factor: 1.000

4.  Surgical treatment of bone metastases in patients with lung cancer.

Authors:  Sandra Utzschneider; Ewa Wicherek; Patrick Weber; Gerwin Schmidt; Volkmar Jansson; Hans Roland Dürr
Journal:  Int Orthop       Date:  2010-06-18       Impact factor: 3.075

5.  Diagnosis of a previously unidentified primary site in patients with spinal metastasis: diagnostic usefulness of laboratory analysis, CT scanning and CT-guided biopsy.

Authors:  Yoichi Iizuka; Haku Iizuka; Satoshi Tsutsumi; Yumi Nakagawa; Takashi Nakajima; Yasunori Sorimachi; Tsuyoshi Ara; Masahiro Nishinome; Takayuki Seki; Kenji Takagishi
Journal:  Eur Spine J       Date:  2009-06-16       Impact factor: 3.134

6.  Metastatic bone tumors: Analysis of factors affecting prognosis and efficacy of CT and 18F-FDG PET-CT in identifying primary lesions.

Authors:  Hirofumi Shimada; Takao Setoguchi; Masahiro Yokouchi; Hiromi Sasaki; Yasuhiro Ishidou; Ichiro Kawamura; Masahiko Abematsu; Satoshi Nagano; Setsuro Komiya
Journal:  Mol Clin Oncol       Date:  2014-06-23

7.  Features of Spinal Metastases: A Retrospective View.

Authors:  Koray Başdelioğlu
Journal:  Int J Spine Surg       Date:  2021-02-12

8.  Atypical neurofibroma and osteosclerotic metastasis.

Authors:  Neeraj Varyani; Anubhav Thukral; Sunny Garg; Kailash Kumar Gupta; Ravi Tandon; Kamlakar Tripathi
Journal:  Case Rep Oncol Med       Date:  2012-01-15

9.  Clinical Impact of F-18 FDG PET-CT on Biopsy Site Selection in Patients with Suspected Bone Metastasis of Unknown Primary Site.

Authors:  Su Woong Yoo; Md Sunny Anam Chowdhury; Subin Jeon; Sae-Ryung Kang; Changho Lee; Zeenat Jabin; Jahae Kim; Sang-Geon Cho; Ho-Chun Song; Hee-Seung Bom; Jung-Joon Min; Seong Young Kwon
Journal:  Nucl Med Mol Imaging       Date:  2020-07-06

10.  Imaging findings of solitary spinal bony lesions and the differential diagnosis of benign and malignant lesions.

Authors:  Young Soo Kim; In Ho Han; In Sook Lee; Jung Sub Lee; Byung Kwan Choi
Journal:  J Korean Neurosurg Soc       Date:  2012-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.